Wound Care Biologics Market Global Trends, Share, Size, Growth, Opportunities and Forecast to 2030
Wound Care Biologics Market Highlights
Growing
aging population, increasing prevalence of chronic diseases and burn injuries,
and increasing healthcare expenditure are expected to drive the growth of the
market. According to the American Diabetes Association, in 2015, about 30.3
million suffer from diabetes in the Americas. Moreover, in the US, 486,000 were
suffering from burn injuries from 2011 to 2015. On other hand, the high cost of
treatment, lack of awareness, and poor education and training can restrain the
market growth over the assessment period.
The
global wound care biologics market is
anticipated to have held a market value of USD 1.20 billion in the year 2030
and is expected to grow at a CAGR of 10.50% during the forecast period.
Biologic wound care products involve assisting in wound healing. Biologic wound
care products restore the tissue integrity by regeneration and scar formation.
It is gaining popularity as a treatment modality for the management of chronic
wounds and burns injuries.
Regional
Analysis
Geographically,
the Americas is expected to dominate the global market owing to the presence of
well-developed healthcare sector, rising prevalence of diabetes, increasing
rate of accidents and rising expenditure for the healthcare sector. Europe is
expected to hold the second largest position in the global market owing to the
growing prevalence of chronic diseases coupled with increasing occurrences of
burn cases. Asia-Pacific is expected to be the fastest growing market owing to
the large population base of the diabetic patients and increasing developments
in the healthcare segment. Furthermore, the Middle East and Africa region is
expected to account for the least market share in the global market.
Segmentation
The
global wound care biologics market insights have been segmented into product type, wound type,
and end user.
Based
on product type, the market is segmented into biological skin substitutes and
topical agents. The biological skin substitutes segment is expected to account
for the largest share and fastest growing segment of the global market in 2017.
The market growth of the segment is attributed to increasing adoption and
result oriented product.
Based
on wound type, the market is segmented into ulcers, surgical & traumatic
wounds, and burns. The ulcer segment has been further segmented into diabetic
foot ulcer, pressure ulcer, venous leg ulcer, and others ulcer.
The
global wound care biologics market, by end user, has been segmented into
hospitals, clinics, and other end users.
Wound Care Biologics Market Players
Some of the
prominent players in the global wound care biologics market are Integra
LifeSciences Corporation (US), Smith & Nephew (UK), Wright Medical (US),
Mölnlycke Health Care AB (Sweden), MiMedx Group (US), Vericel Corporation (US),
Anika Therapeutics (US), Osiris Therapeutics (US), Marine Polymer Technologies,
Inc. (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), and
Organogenesis (US).
About Market
Research Future:
At Market Research Future
(MRFR), we enable our customers to unravel the complexity of various industries
through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR),
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment